Transcriptomic and proteomic analyses from large-scale datasets such as TCGA and CPTAC have demonstrated that MDK is consistently overexpressed in aggressive tumor types, including hepatocellular carcinoma, lung adenocarcinoma, and ovarian cancer. This evidence concerns the gene MDK and lung adenocarcinoma.